News

Filter

Current filters:

None

7860 to 7869 of 96601 results

UK's Proximagen boosted by US lorcaserin news with respect to its own obesity drug candidate

14-05-2012

UK-based biotechnology firm Proximagen (AIM: PRX) saw its shares leap 20.1% to 257.5 pence, on the back…

BiotechnologyMetabolicsProximagenRegulationResearch

Takeda's vedolizumab meets primary endpoints in Ph III Crohn's disease study

13-05-2012

Japan's largest drugmaker Takeda Pharmaceutical (TYO: 4502) has reported positive top-line results from…

Gastro-intestinalsPharmaceuticalResearchTakeda Pharmaceuticalsvedolizumab

Seikagaku licenses lumbar disc herniation product to Kaken

13-05-2012

Japanese companies Seikagaku Corp (TYO: 4548) and Kaken Pharmaceutical (TYO: 4521) have concluded a basic…

Asia-PacificcondoliaseKaken PharmaLicensingPharmaceuticalSeikagaku

Big pharma and biotech increasingly tackling rare and niche diseases, new report finds

13-05-2012

Rare and niche diseases are being increasingly spotlighted by pharmaceutical and biotechnology corporations…

BiotechnologyPharmaceuticalRare diseasesResearch

Oncologists backing of combo products supporting cytotoxic market

13-05-2012

The popularity of combination therapies in the treatment of cancer is set to increase, which will help…

BiotechnologyGemzarMarkets & MarketingOncologyPharmaceuticalTaxotere

EU draft opinion on ACTA still flawed, says MSF, urging member states not to sign

11-05-2012

The European Union Parliament Committee on Development released its draft opinion this week on the Anti-Counterfeiting…

EuropeGenericsGlobalPatentsPharmaceuticalPolitics

UK's NICE negative on Sanofi's Jevtana, but backs Botox for migraine

11-05-2012

Confirming previous negative guidance (The Pharma Letter January 12), UK drugs watchdog the National…

AllerganBotoxEuropeJevtanaNeurologicalOncologyPharmaceuticalPricingRegulationSanofi

7860 to 7869 of 96601 results

Back to top